CHA sent a comment letter to the FDA on draft guidance that recommends how and when manufacturers provide additional information in drug shortage notifications to the agency. Our letter urges the FDA to address the specific challenges facing the pediatric drug supply chain through transparency requirements, developing proactive shortage mitigation plans, and ensuring an accounting of pediatric drugs on the FDA drug shortages list.
CHA Submits Comments on FDA Drug Shortage Guidance
Children’s Hospital Association sends a comment letter to the FDA on draft drug shortage guidance to highlight the need for an efficient pediatric supply chain.
Related Content
Global Preventing Youth Suicide Collaborative
Members of the collaborative are dedicated to implementing a standard of care designed to identify and support youth at risk for suicide.
Sep. 18, 2026
Joint Statement on Workplace Violence and Protecting Those Who Care
A safe and supported health care workforce is essential to delivering safe, high-quality patient care.
Sep. 17, 2026
Pharmacy Technicians Capture 98% of Medication Histories
Specially trained technicians catch errors before they reach patients and remove the burden from nurses.
Sep. 10, 2026
